Lantheus Stock Quote LNTH - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

63.435

Bid

63.38

Ask

63.54

Volume

145,886

61.47 Day's Range 63.91

50.20 52 Week Range 100.8505

Market Cap

4.361B

Previous Close

62.33

Open

62.10

Last Trade

63.4361

Last Trade Time

11:04:50

Financial Volume

$ 9,143,838

VWAP

62.678

Average Volume (3m)

887,138

Shares Outstanding

68,525,556

Dividend Yield

PE Ratio

13.35

Earnings Per Share (EPS)

4.77

Revenue

1.3B

Net Profit

326.66M

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in ... Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.lantheus.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Lantheus Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker LNTH. The last closing price for Lantheus was $62.33. Over the last year, Lantheus shares have traded in a share price range of $ 50.20 to $ 100.8505.

Lantheus currently has 68,525,556 shares outstanding. The market capitalization of Lantheus is $4.36 billion. Lantheus has a price to earnings ratio (PE ratio) of 13.35.

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	2.485	4.0771123872	60.95	65.255	59.5635	737554	61.46854616	CS
4	4.885	8.34329632792	58.55	65.255	57.92	751936	60.34643607	CS
12	10.935	20.8285714286	52.5	69.73	51.02	887138	59.68207303	CS
26	-6.845	-9.73961297666	70.28	79.2	50.2	1104721	61.20620638	CS
52	-27.355	-30.129970261	90.79	100.8505	50.2	1082759	70.28616302	CS
156	41.705	191.923607915	21.73	100.8505	19.301	980044	60.77805783	CS
260	39.495	164.974937343	23.94	100.8505	8.67	772483	50.27470274	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGOXNext e GO NV	$ 0.0599 (66.39%)	251.96M
NVFYNova Lifestyle Inc	$ 3.4199 (62.08%)	20.08M
RWODRedwoods Acquisition Corporation	$ 10.6607 (33.32%)	5.42M
SHOTWSafety Shot Inc	$ 0.3998 (33.27%)	6.3k
TWGTop Wealth Group Holding Ltd	$ 2.28 (23.24%)	5.27M
SBFMSunshine Biopharma Inc	$ 2.1195 (-36.16%)	6.62M
ISPCiSpecimen Inc	$ 0.291 (-30.88%)	1.5M
NCRANocera Inc	$ 1.00 (-21.88%)	3k
BGLCBioNexus Gene Lab Corporation	$ 0.67 (-21.05%)	421.34k
DWSNDawson Geophysical Company	$ 1.74 (-20.55%)	22.65k
EGOXNext e GO NV	$ 0.0599 (66.39%)	251.96M
AGBAAGBA Group Holding Ltd	$ 1.165 (13.11%)	84.35M
SQQQProShares UltraPro Short QQQ	$ 12.385 (2.61%)	76.05M
SINTSiNtx Technologies Inc	$ 0.0465 (16.25%)	59.46M
TQQQProShares UltraPro QQQ	$ 51.50 (-2.37%)	36.08M